Georges De Feu

Georges De Feu is the current CEO of LynxCare. Prior to this, they were with LynxCare, Inc. as well as Zorgpunt cvba and PharmaLegal BVBA. From January 2012 to January 2015, Georges was the Co-Founder and Chairman of the Board for Qualenica. In this role, they were responsible for the business model, legal framework, sales & marketing, and R&D. Georges successfully set up the company, including the legal framework and converting the company to a CVBA structure. Georges also registered trademarks and contracted trade secrets, settled an international trademark dispute, setup a sales and commercial strategy, drafted pharmaceutical Quality and Distribution agreements (GDP), obtained a governmental drug raw material distribution authorization, successfully conducted a capital round of approx.. 0,5mo eur, raised funding at public pharmacies and private investors, presented at investor platforms (BAN, BAE/Club Lorraine,..), obtained funding of the Royal Baudouin Foundation, conducted IWT grant applications in cooperation with KUL, VUB, UGent, laureate of multiple competitions (American Chambers of Commerce, ING,..), and set up a viable business. Georges sold their stake in the business in 2015.

Georges De Feu has a Master of Laws from KU Leuven, a PharmD from KU Leuven, and a Bachelor in de Rechten from KU Leuven. Georges also has a Bachelor of Pharmacy from KU Leuven. Georges has studied Corporate and Organisational Strategy at the London School of Economics and Political Science (LSE), and has done a thesis at the Max Planck - Center for Molecular Biomedicine (CMB) at Friedrich-Schiller-Universität Jena.

Some direct reports include Jasper Theunis - BI Consultant, Thomas Lemaitre - CISO, and Nadia Rabah - Project Manager.